Navigation Links
MDS Analytical Technologies Releases MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 Cellular Imaging Software
Date:4/26/2009

Enhancements Increase Flexibility and High-Content Screening Throughput

SUNNYVALE, CA, April 27 /PRNewswire-FirstCall/ - MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences research, today announced at the Society for Biomolecular Sciences (SBS) Conference and Exhibition 2009 in Lille, France, the availability of the MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 image acquisition and analysis software. These advancements are designed to accelerate the throughput of High-Content Screening (HCS) and expand toxicity applications to include micronuclei detection.

MetaXpressPowerCore(TM) software improves workflow and significantly reduces overall time required for HCS screens by dramatically increasing image analysis speeds. Image analysis is improved by leveraging a novel parallel-processing infrastructure that can be scaled to the user's throughput need. MetaXpressPowerCore(TM) software integrates with the existing MetaXpress(R) platform and MDCStore(TM) data-management solution, and is licensed by the number of processes required. MetaXpressPowerCore(TM) is compatible with the entire suite of MetaXpress(R) application modules.

MetaXpress(R) 3.0 software introduces a number of ease-of-use improvements, including new data- management utilities, such as database optimization, data archival and deletion. MetaXpress(R) 3.0 analysis is compatible with Microsoft's Windows Vista operating system, and runs all of the most recent features of MetaMorph(R) 7.6 software.

"Cellular imaging technology has become integral to drug discovery, research and screening, and improvements in flexibility and speed are critical for customers," said Andy Boorn, President of MDS Analytical Technologies. "The next milestone for HCS is scaling up to primary screening with imaging technology. Elimination of image analysis bottlenecks with these new products is a major accomplishment toward realizing this goal."

Another enhancement to MetaXpress(R) 3.0 software is the release of the Micronuclei Application Module that allows users to find, evaluate and quantitate micronuclei in nucleated cells for HCS. This product uses a proprietary algorithm that is a significant improvement over existing competitive micronuclei detection methods. Using additional probes, this new application module makes it possible for users to additionally differentiate between mitotic, apoptotic, and necrotic cells, expanding the toxicology measurement suite significantly.

MDS Analytical Technologies at SBS Conference and Exhibition 2009

MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 software programs are being presented to attendees at the Society for Biomolecular Sciences Conference and Exhibition 2009, which is being held April 26-30, in Lille, France. MDS Analytical Technologies can be found at booth 76.

About MetaXpress(R) Software

The MetaXpress(R) program is based on the MetaMorph(R) software backbone, and is used to power the suite of cellular imaging instruments and analysis software for automated imaging and HCS. MetaXpress(R) software is integrated with a data-management solution, turnkey application modules, and the PowerCore analysis option that increases the flexibility and overall speed of workflow.

About MDS Analytical Technologies

MDS Analytical Technologies, a business unit of MDS Inc., is focused on the research, design, manufacture and marketing of state-of-the-art tools for mass-spectrometry, drug discovery and bioresearch. MDS Analytical Technologies' products are designed to help accelerate the complex process of discovering and developing new drug compounds, and are sold to research scientists around the world. The mass-spectrometer product lines are also sold globally through joint ventures with two of the world's leading analytical instrumentation and life-sciences companies, Life Technologies Corporation and PerkinElmer, Inc. Find out more at www.mdssciex.com or www.moleculardevices.com.

About MDS Inc.

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS, Inc. has more than 5,000 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection
2. MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food
3. MDS Analytical Technologies Laser Capture Microdissection Helps Facilitate Discovery of Potential New Colon-Cancer Biomarker
4. Polymathic Analytical Labs Launches New Website
5. Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC
6. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
7. Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform
8. MDS Analytical Technologies Acquires Blueshift Biotechnologies
9. Pace Analytical Services, Inc., Purchases Laucks Testing Laboratory, Inc.
10. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
11. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology: